“…Each 3D printing method has a unique set of tradeoffs in resolution, cost-efficiency, biocompatibility, and output volume, enabling the use of 3D printing in a wide range of applications ( Bakhshinejad and D'souza, 2015 ; Park et al., 2015 ). The ability to use biomaterials in 3D printing processes ( Chia and Wu, 2015 ), along with microscale and nanoscale 3D printing ( You et al., 2018 ), can enable the fabrication of a wide range of laboratory instruments for clinical and point-of-care applications ( Aimar et al., 2019 ; Amin et al., 2016b ; Douroumis, 2019 ; Knowlton et al., 2015c ; Yenilmez et al., 2016a ), including organ-on-a-chip devices ( Jain et al., 2020 ; Knowlton and Tasoglu, 2016 ; Knowlton et al., 2016b , 2016c ), tissue engineering ( Knowlton et al., 2018 ; Sears et al., 2016 ; Zhang et al., 2019 ), wound healing ( Joseph et al., 2019 ; Tabriz et al., 2020 ), fertility and embryology research ( Kanakasabapathy et al., 2019 ; Knowlton et al., 2015d ; Potluri et al., 2018 ), cancer research ( Knowlton et al., 2015a , 2016a ), stem cell research ( Javaid and Haleem, 2020 ; Tasoglu and Demirci, 2013 ), and circulating tumor cell isolation ( Chen et al., 2020 ).…”